2026-04-13T07:24:57Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/112022025-10-24T10:39:49Zcom_2072_378070com_2072_378040col_2072_378092

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study Guilbert, Theresa Tolcachier, Alberto Fiocchi, Alessandro Katelaris, Constance Phipatanakul, Wanda Begin, Philippe de Mir Messa, Ines Institut Català de la Salut [Guilbert TW] Department of Pediatrics, Cincinnati Children’s Hospital and University of Cincinnati, Cincinnati, OH, USA. [Tolcachier A] Center for Allergy and Respiratory Diseases, Buenos Aires, Argentina. [Fiocchi AG] Bambino Gesù Children’s Hospital IRCCS, Rome, Italy. [Katelaris CH] Department of Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia. Immunology & Allergy Unit, Western Sydney University, Sydney, NSW, Australia. [Phipatanakul W] Department of Allergy and Immunology, Boston Children’s Hospital, Boston, MA, USA. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. [Begin P] Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, QC, Canada. [de Mir I] Unitat de Pneumologia Pediàtrica i Fibrosi Quística, Vall d’Hebron Hospital Universitari, Barcelona, Spain Vall d'Hebron Barcelona Hospital Campus Asma infantil Anticossos monoclonals - Ús terapèutic DISEASES::Respiratory Tract Diseases::Bronchial Diseases::Asthma Other subheadings::Other subheadings::Other subheadings::/drug therapy CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal Other subheadings::Other subheadings::/therapeutic use NAMED GROUPS::Persons::Age Groups::Child ENFERMEDADES::enfermedades respiratorias::enfermedades bronquiales::asma Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales Otros calificadores::Otros calificadores::/uso terapéutico DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño Asthma control; Lung function; Pediatric asthma Control del asma; Función pulmonar; Asma pediátrica Control de l'asma; Funció pulmonar; Asma pediàtrica Research sponsored by Sanofi and Regeneron Pharmaceuticals Inc. ClinicalTrials.gov Identifier: NCT02948959. Medical writing/editorial assistance was provided by Natalia Crespo, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals Inc., according to the Good Publication Practice guidelines: 2022 update. 2024-03-18T13:38:57Z 2024-03-18T13:38:57Z 2024-03-05 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Guilbert TW, Tolcachier A, Fiocchi AG, Katelaris CH, Phipatanakul W, Begin P, et al. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study. J Asthma Allergy. 2024 Mar 5;17:143–59. 1178-6965 https://hdl.handle.net/11351/11202 10.2147/JAA.S416292 38476213 001179622600001 http://hdl.handle.net/11351/11202 eng Journal of Asthma and Allergy;17 https://doi.org/10.2147/JAA.S416292 Attribution-NonCommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0/ info:eu-repo/semantics/openAccess application/pdf Dove Medical Press Scientia